Preventing and Treating Missing Data in Longitudinal Clinical Trials
A Practical Guide

"This is a timely introduction to handling missing data in clinical trials, by a statistician with wide practical experience. Sensibly, the author not only focuses on the handling of the missing data in the analysis but also explores ways in which the occurrence of missing data can be minimized through appropriate design and conduct. The book touches on the most recent developments from academia and the regulators and is presented at a level that is accessible and useful for statisticians and non-statisticians alike, and so should be both widely read and influential."
Mike Kenward, London School of Hygiene and Tropical Medicine

"Designing experiments to minimize missing data and understanding the most appropriate statistical methods to implement when analyzing a data set with missing values is of critical importance. Dr. Mallinckrodt’s text is approachable to any researcher challenged with issues surrounding missing data yet is technically comprehensive enough to be a valuable addition to any statistician’s library."
Adam Meyers, Biogen IDEC

"Dr. Mallinckrodt has worked tirelessly and successfully to promote statistically sound and practically relevant and feasible methodology to handle incomplete data from clinical trials. As an opinion leader, he is well respected by the biopharmaceutical industry, the regulatory authorities, and academe. Dr. Mallinckrodt tops off quality and relevance with an engaging and savory writing style. This highly recommended text is at the same time a page turner!"
Geert Molenberghs, Interuniversity Institute for Biostatistics and statistical Bioinformatics

"Craig Mallinckrodt blended his many years of research and real-world experience on missing data with recommendations in an NRC guidance document. The result is an excellent book that offers a principled and comprehensive road map of strategies to prevent and treat missing data in longitudinal clinical trials. It is a must-read for all statisticians and non-statisticians who are interested in this topic."
Christy Chuang-Stein, Pfizer, Inc.

"Dr. Mallinckrodt has made a difficult topic accessible to a broad audience by providing clear exposition of important concepts related to missing data. The book is a valuable translation of theory into practice, including design considerations for prevention of missing data, a clear explanation of estimands, a sensible description of an analytical road map containing sensitivity analyses, real-life examples, and open access to sophisticated and readily available software tools. There are many aspects of this practical guide that will be useful to many involved in design, analysis, and interpretation of clinical trials, whether they be in industry, academia, or government."
Stephen J. Ruberg, Eli Lilly & Company

"At $37, this monograph is good value, and I recommend all those involved in the design, conduct or analysis of trials to peruse a copy. Non-statisticians will inevitably be frustrated at times, but if this monograph fosters improved discussion and understanding of the issues raised by missing data in study teams|and how they might be addressed|it will have done its work. In his choice of audience Mallinckrodt set himself a high bar; while this has not been cleared entirely cleanly, it has nevertheless been cleared. In addition, Mallinckrodt's wry turn of phrase was an unexpected pleasure. You'll miss this if you don't buy it!"
James R. Carpenter, London School of Hygiene & Tropical Medicine for the Journal of Biopharmaceutical Statistics